Adenoviral vectors: prospects for gene delivery to the central nervous system
- 20 August 1999
- journal article
- editorial
- Published by Springer Nature in Gene Therapy
- Vol. 6 (8) , 1349-1350
- https://doi.org/10.1038/sj.gt.3301013
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Adenoviral vectors for in vivo gene delivery to oligodendrocytes: transgene expression and cytopathic consequencesGene Therapy, 1999
- A model for long-term transgene expression in spinal cord regeneration studiesGene Therapy, 1999
- Inflammatory responses and their impact on β-galactosidase transgene expression following adenovirus vector delivery to the primate caudate nucleusGene Therapy, 1999
- High Doses of a Helper-Dependent Adenoviral Vector Yield Supraphysiological Levels ofα1-Antitrypsin with Negligible ToxicityHuman Gene Therapy, 1998
- Deletion of multiple immediate–early genes from herpes simplex virus reduces cytotoxicity and permits long-term gene expression in neuronsGene Therapy, 1998
- Inhibition of NF-κB Activation in Combination with Bcl-2 Expression Allows for Persistence of First-Generation Adenovirus Vectors in the Mouse LiverJournal of Virology, 1998
- Toxicological Comparison of E2a-Deleted and First-Generation Adenoviral Vectors Expressingα1-Antitrypsin after Systemic DeliveryHuman Gene Therapy, 1998
- Persistent transgene expression in mouse liver following in vivo gene transfer with a ΔE1/ΔE4 adenovirus vectorGene Therapy, 1997
- A helper-dependent adenovirus vector system: Removal of helper virus by Cre-mediated excision of the viral packaging signalProceedings of the National Academy of Sciences, 1996